Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix,...
Hemostasis Management
This channel includes news and new technology innovations for devices to help stop bleeding at vascular access sites. These include coated or treated bandages to accelorate or augment the clotting cascade, vascular closure devices and compression devices, including radial artery compression systems.
-
-
April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device.
-
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon...
-
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with ...
News | Radial Access | December 30, 2019
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of...
Videos | Vascular Closure Devices | October 17, 2019
News | Hemostasis Management | August 29, 2019
August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo...
Technology | Vascular Closure Devices | April 03, 2019
April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore...
Technology | Hemostasis Management | February 01, 2019
February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now...
Technology | Vascular Closure Devices | December 20, 2018
December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S....
News | Vascular Closure Devices | November 21, 2018
November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal...
Technology | Vascular Closure Devices | November 05, 2018
November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control...
Videos | Hemostasis Management | September 27, 2018
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018
May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...
Technology | Vascular Closure Devices | April 10, 2018
April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for...
The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.
Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site...
News | Vascular Closure Devices | October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc. announced today an agreement to sell certain products from their...
News | Vascular Closure Devices | September 12, 2016
September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16...
Nanoparticles (green) help form clots in an injured liver. The researchers added color to the scanning electron microscopy image after it was taken. Image courtesy of Erin Lavik, Ph.D.
News | Hemostasis Management | August 24, 2016
August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to...
